[1] |
Siegel R,Ma J,Zou Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1): 9-29.
|
[2] |
中华医学会核医学分会. 131I治疗分化型甲状腺癌指南(2014版)[J]. 中华核医学与分子影像杂志, 2014, 34(4): 264-278.
|
[3] |
Gharib H,Papini E,Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules[J]. J Endocrinol Invest, 2010, 33(5 Suppl): 1-50.
|
[4] |
Xu D,Wang LP,Long B, et al. Radiofrequency ablation for postsurgical thyroid removal of differentiated thyroid carcinoma[J]. Am J Transl Res, 2016, 8(4): 1876-1885.
|
[5] |
Long B,Li L,Yao L, et al. Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma[J]. J Cancer Res Ther, 2015, 11(8): 244-247.
|
[6] |
Iyer NG,Morris LG,Tuttle RM, et al. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy[J]. Cancer, 2011, 117(19): 4439-4446.
|
[7] |
Patel SS,Goldfarb M. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration[J]. J Surg Oncol, 2013, 107(6): 665-672.
|
[8] |
乔法敏. 重复131碘清甲治疗分化型甲状腺癌疗效分析[J]. 现代医药卫生, 2016, 32(23): 3680-3681.
|
[9] |
王立平, 徐栋, 李林法, 等. 射频消融去除分化型甲状腺癌术后残留甲状腺组织初步研究[J]. 中华超声影像学杂志, 2015, 24(6): 549-551.
|
[10] |
Wiggermann P,Zuber-Jerger I,Zausig Y, et al. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results[J]. Clin Hemorheol Microcirc, 2011, 49(1-4): 43-54.
|
[11] |
Baek JH,Moon WJ,Kim YS, et al. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules[J]. World J Surg, 2009, 33(9): 1971-1977.
|
[12] |
王飞亮, 缪刚, 韦军民, 等. 甲状腺全切除术中对甲状旁腺特异性附着脂肪进行保护的临床和解剖研究[J]. 中华外科杂志, 2016, 54(11): 859-863.
|
[13] |
Lappas D,Noussios G,Anagnostis P, et al. Location,number and mor-phology of parathyroid glands: results from a large anatomical series[J]. Anat Sci Int, 2012, 87(3): 160-164.
|
[14] |
Silaghi H,Valea A,Ghervan C, et al. Ectopic intrathyroid parathyroidadenoma: diagnostic and therapeutic challenges due to multiple osteo-lytic lesions[J]. Med Ultrason, 2011, 13(3) :241-244.
|
[15] |
Verburg FA,Lassmann M,Mäder U, et al. The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patients[J]. Eur J Nucl Med Mol Imaging, 2011, 38(4): 673-680.
|
[16] |
刘晔, 晋建华, 刘建中, 等. 放射性131I去除分化型甲状腺癌术后残留甲状腺组织的疗效与影响因素分析[J]. 中国药物与临床, 2013, 13(5): 556-558.
|